199 related articles for article (PubMed ID: 1788163)
1. Formulation influence on conjunctival penetration of four beta blockers in the pigmented rabbit: a comparison with corneal penetration.
Ashton P; Podder SK; Lee VH
Pharm Res; 1991 Sep; 8(9):1166-74. PubMed ID: 1788163
[TBL] [Abstract][Full Text] [Related]
2. Lipophilicity influence on conjunctival drug penetration in the pigmented rabbit: a comparison with corneal penetration.
Wang W; Sasaki H; Chien DS; Lee VH
Curr Eye Res; 1991 Jun; 10(6):571-9. PubMed ID: 1680041
[TBL] [Abstract][Full Text] [Related]
3. Different effects of absorption promoters on corneal and conjunctival penetration of ophthalmic beta-blockers.
Sasaki H; Igarashi Y; Nagano T; Nishida K; Nakamura J
Pharm Res; 1995 Aug; 12(8):1146-50. PubMed ID: 7494826
[TBL] [Abstract][Full Text] [Related]
4. Rate limiting barrier to the penetration of ocular hypotensive beta blockers across the corneal epithelium in the pigmented rabbit.
Shih RL; Lee VH
J Ocul Pharmacol; 1990; 6(4):329-36. PubMed ID: 1982948
[TBL] [Abstract][Full Text] [Related]
5. Ocular absorption of Pz-peptide and its effect on the ocular and systemic pharmacokinetics of topically applied drugs in the rabbit.
Chung YB; Han K; Nishiura A; Lee VH
Pharm Res; 1998 Dec; 15(12):1882-7. PubMed ID: 9892473
[TBL] [Abstract][Full Text] [Related]
6. Location of penetration and metabolic barriers to levobunolol in the corneal epithelium of the pigmented rabbit.
Ashton P; Wang W; Lee VH
J Pharmacol Exp Ther; 1991 Nov; 259(2):719-24. PubMed ID: 1941620
[TBL] [Abstract][Full Text] [Related]
7. Systemic absorption pathways of topically applied beta adrenergic antagonists in the pigmented rabbit.
Lee YH; Kompella UB; Lee VH
Exp Eye Res; 1993 Sep; 57(3):341-9. PubMed ID: 7901046
[TBL] [Abstract][Full Text] [Related]
8. Ocular pharmacokinetics of atenolol, timolol and betaxolol cocktail: Tissue exposures in the rabbit eye.
Fayyaz A; Vellonen KS; Ranta VP; Toropainen E; Reinisalo M; Valtari A; Puranen J; Ricci GD; Heikkinen EM; Gardner I; Ruponen M; Urtti A; Jamei M; Del Amo EM
Eur J Pharm Biopharm; 2021 Sep; 166():155-162. PubMed ID: 34139290
[TBL] [Abstract][Full Text] [Related]
9. Modification of ocular permeability of peptide drugs by absorption promoters.
Sasaki H; Yamamura K; Mukai T; Nishida K; Nakamura J; Nakashima M; Ichikawa M
Biol Pharm Bull; 2000 Dec; 23(12):1524-7. PubMed ID: 11145191
[TBL] [Abstract][Full Text] [Related]
10. Role of enzymatic lability in the corneal and conjunctival penetration of timolol ester prodrugs in the pigmented rabbit.
Chien DS; Sasaki H; Bundgaard H; Buur A; Lee VH
Pharm Res; 1991 Jun; 8(6):728-33. PubMed ID: 2062802
[TBL] [Abstract][Full Text] [Related]
11. Ocular permeability of FITC-dextran with absorption promoter for ocular delivery of peptide drug.
Sasaki H; Yamamura K; Tei C; Nishida K; Nakamura J
J Drug Target; 1995; 3(2):129-35. PubMed ID: 7496726
[TBL] [Abstract][Full Text] [Related]
12. Importance of the noncorneal absorption route in topical ophthalmic drug delivery.
Ahmed I; Patton TF
Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):584-7. PubMed ID: 3884542
[TBL] [Abstract][Full Text] [Related]
13. Improving the safety of topically applied timolol in the pigmented rabbit through manipulation of formulation composition.
Podder SK; Moy KC; Lee VH
Exp Eye Res; 1992 May; 54(5):747-57. PubMed ID: 1623960
[TBL] [Abstract][Full Text] [Related]
14. Ocular ketone reductase distribution and its role in the metabolism of ocularly applied levobunolol in the pigmented rabbit.
Lee VH; Chien DS; Sasaki H
J Pharmacol Exp Ther; 1988 Sep; 246(3):871-8. PubMed ID: 3047365
[TBL] [Abstract][Full Text] [Related]
15. Basis for dosing time-dependent changes in the ocular and systemic absorption of topically applied timolol.
Lee VH; Yamahara H; Gurny R; Sintzel MB; Martenet M; Gex-Fabry M; Balant L; Ohdo S; Podder SK
J Ocul Pharmacol Ther; 1996; 12(2):103-13. PubMed ID: 8773926
[TBL] [Abstract][Full Text] [Related]
16. The effect of timolol, betaxolol and levobunolol on the surface of rabbit cornea.
Follmann P; Varga M; Daróczy J
Int Ophthalmol; 1989 Jan; 13(1-2):81-4. PubMed ID: 2663750
[TBL] [Abstract][Full Text] [Related]
17. Conjunctival penetration of insulin and peptide drugs in the albino rabbit.
Hayakawa E; Chien DS; Inagaki K; Yamamoto A; Wang W; Lee VH
Pharm Res; 1992 Jun; 9(6):769-75. PubMed ID: 1384027
[TBL] [Abstract][Full Text] [Related]
18. Improving the ocular to systemic ratio of topical timolol by varying the dosing time.
Ohdo S; Grass GM; Lee VH
Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2790-8. PubMed ID: 1894477
[TBL] [Abstract][Full Text] [Related]
19. Ocular drug delivery using 20-kHz ultrasound.
Zderic V; Vaezy S; Martin RW; Clark JI
Ultrasound Med Biol; 2002 Jun; 28(6):823-9. PubMed ID: 12113795
[TBL] [Abstract][Full Text] [Related]
20. Formulation influence on ocular and systemic absorption of topically applied atenolol in the pigmented rabbit.
Lee YH; Lee VH
J Ocul Pharmacol; 1993; 9(1):47-58. PubMed ID: 8463732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
